Benign prostatic hyperplasia: a new metabolic disease?

Vignozzi, L; Rastrelli, G; Corona, G; Gacci, M; Forti, G; Maggi, M

Vignozzi, L; Rastrelli, G; Corona, G; Gacci, M; Forti, G; Maggi, M.

Affiliation

Vignozzi L; Sexual Medicine and Andrology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy.

J Endocrinol Invest ; 37(4): 313-22, 2014 Apr.

Article in En | MEDLINE | ID: mdl-24458832

Subject(s)

Prostatic Hyperplasia/etiology; Aged; Aged, 80 and over; Bacterial Infections; Estradiol/physiology; Humans; Hypercholesterolemia/complications; Hypogonadism/complications; Male; Metabolic Syndrome/complications; Middle Aged; Prostate/pathology; Prostatic Hyperplasia/pathology; Prostatic Hyperplasia/physiopathology; Prostatitis/complications; Prostatitis/microbiology; Testosterone/physiology; Toll-Like Receptors/physiology; Urinary Bladder/physiopathology; Urinary Bladder, Overactive/complications; Urinary Bladder, Overactive/physiopathology; Virus Diseases

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: J Endocrinol Invest Year: 2014 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google